2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
2
Neuralgia
2
Neoplasms
2
Chronic Pain
2
Wounds and Injuries
1
Peripheral Nervous System Diseases
1
Pain, Intractable
1
Lymphoma, Follicular
1
HIV Infections
1
Bronchiolitis Obliterans Syndrome
1
Acquired Immunodeficiency Syndrome
1
AIDS-Related Complex
1
Interventions
resiniferatoxin
3
Ketamine
3
Morphine
2
Methadone
2
Dexmedetomidine
2
ziconotide
1
substance P-saporin
1
Standard of Care
1
Sodium Chloride
1
Ropivacaine
1
Registries
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Midazolam
1
Lidocaine
1
Infusion Pumps, Implantable
1
Hydromorphone
1
Fentanyl
1
Calcium Dobesilate
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain, Intractable
×
ziconotide
×
Clear all
NCT00996983
2023-03-24
ZIDON
National Cancer Institute, Naples
Phase 2
Unknown
16 enrolled